Sign In
Buy KVUE
$16.83
-0.490 (-2.83%)
At Close: Jun 03, 2026
J&J Investors Need to Decide Soon If They Want Kenvue Stock
02:27pm, Monday, 14'th Aug 2023
The $40 billion exchange offer for shares of Kenvue expires Friday but brokerage firms want retail investors to make their instructions before then
Is Kenvue Stock a Buy After Earnings?
08:55am, Friday, 11'th Aug 2023
Kenvue recently held its first earnings call as a standalone public company. While financial results are limited, the stock trades for a noticeable discount to its peers.
KVUE Stock Alert: Kenvue to Join the S&P 500
10:25am, Thursday, 10'th Aug 2023
Kenvue (NYSE: KVUE ) stock is a hot topic among traders on Thursday following news that it will be added to the S&P 500 . Investors will note that Kenvue is joining the S&P 500, as well as the S&P 100
J&J spinoff Kenvue set to join S&P 500 index
08:52am, Thursday, 10'th Aug 2023
Kenvue is set to make its debut in the S&P 500 index, a move confirmed by S&P Dow Jones Indices following the impending completion of Johnson and Johnson's exchange offer for Kenvue stock. The inclusi
Kenvue Will be Added to S&P 500 After J&J Exchange Offer
06:16pm, Wednesday, 09'th Aug 2023
The Johnson & Johnson spinoff is the consumer health company that makes Listerine and Tylenol.
Kenvue, the J&J spinoff, will join the S&P 500 index
05:49pm, Wednesday, 09'th Aug 2023
Kenvue Inc., maker of Tylenol, Benadryl and other household names in health-care products, is joining the S&P 500, index provider S&P Dow Jones Indices said late Wednesday.
Johnson & Johnson Plans Exchange Offer for Kenvue
04:10pm, Monday, 07'th Aug 2023
Johnson & Johnson ( JNJ , Financial) has recently announced its intention to split off Kenvue Inc. ( KVUE , Financial) shares through an exchange offer. This move marks the next step in the separation
Dividend Investors in This Unique Stock-Split Stock Have a Decision to Make
07:30am, Tuesday, 25'th Jul 2023
Johnson & Johnson is splitting off its consumer healthcare business to shareholders. They can exchange all, some, or none of their shares for Kenvue stock.
Johnson & Johnson Offers Exchange for Shares of Spinoff Kenvue
11:30am, Monday, 24'th Jul 2023
Johnson & Johnson offers its shareholders the choice to exchange its shares for Kenvue's, the consumer health company it spun off just two months ago.
Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer
09:03am, Monday, 24'th Jul 2023
J&J said it received a waiver that dismisses the share lockup period associated with Kenvue's initial public offering in May.
Johnson & Johnson launches share exchange offering for Kenvue
08:54am, Monday, 24'th Jul 2023
Johnson & Johnson (NYSE:JNJ) (J&J) has launched a share exchange offer for its former consumer health business Kenvue which completed its initial public offering in May. Shareholders of J&J can opt to
J&J begins share exchange offer for consumer health spin-off Kenvue
06:38am, Monday, 24'th Jul 2023
Johnson & Johnson said on Monday it had launched an exchange offer for its investors to exchange J&J's shares with those of its consumer health unit Kenvue.
Johnson & Johnson to spin off at least 80.1% of Kenvue shares in an exchange offer
06:29am, Monday, 24'th Jul 2023
Johnson & Johnson JNJ, +1.07% said Monday it is planning to spin off at least 80.1% of its shares of Kenvue Inc. KVUE, -2.04% through an exchange offer. The consumer goods and healthcare giant announc
Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas
04:47pm, Friday, 21'st Jul 2023
Thibaut Mongon's remarks follow Kenvue's second-quarter earnings beat, which was fueled by resilient demand for brands like Band-Aid, Tylenol and Aveeno.
Kenvue CEO talks earnings, strong demand, stock: 'We are focused on the power of our portfolio'
04:15pm, Thursday, 20'th Jul 2023
Yahoo Finance health care reporter Anjalee Khemlani spoke with Kenvue CEO Thibaut Mongon about the company's latest earnings report, the outlook for growth, product portfolio, and Johnson & Johnson.
